NCT06303466View on ClinicalTrials.gov

Real World Evidence Study of Danish Fabry Patients

Active, not recruitingOBSERVATIONAL

Enrollment

115

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

August 1, 2024

Study Completion Date

December 31, 2024

Conditions

Fabry Disease

Trial Locations (1)

2100

Rigshospitalet, Copenhagen

Sponsors

Collaborators (1)

Amicus Therapeutics

All Listed Sponsors

collaborator

Amicus Therapeutics

INDUSTRY

collaborator

Rigshospitalet, Denmark

OTHER

lead

Caroline Michaela Kistorp

OTHER

NCT06303466 - Real World Evidence Study of Danish Fabry Patients | Biotech Hunter | Biotech Hunter